IL-16 a pro-inflammatory cytokine, a ligand for CD4+, is a chemoattractant molecule expressed by lymphocytes (CD8+ and CD4+), eosinophils, mast cells, and lung epithelium (12) , macrophages, airway epithelial cells of asthmatics (16) . IL-16 is a potent chemoattractant for CD4+ T cells, eosinophils and monocytes mainly derived from activated T cells (17) (18) . CD4+ T cell infiltration is known to occur in tissues at sites of mast cell activation (19) . In addition to being a major effector cell in the elicitation of allergic inflammation, mast cells have been found to be activated in various T cell mediated inflammatory processes and to reside in close physical proximity to T cell. Mast cell activation has been reported to induce T cell migration either directly by the release of chemotactic factors, such as lymphotactin or IL-16, or indirectly by the induction of adhesion molecules expression on endothelial cells. Mast cells are able to present antigens to Tcells, resulting in their activation in either MHC class I or class II restricted and co-stimulatory molecule dependent fashion also, T cell derived mediators, such as beta-chemokines directly induce mast cell degranulation (10) .
IL-16 may play a role in the trafficking of dendritic cells and may be a major chemotactic signal from dendritic cells towards themselves and towards T cells (20) .
IL-16 functions as a chemoattractant factor for CD4+ cells, as a modulator ofT cell activation, Tab. Cytokines generated by mast cell activation inhibitor of HIV replication, and inducer of proinflammatory cytokine production and playa key role in asthma (21) . Previous studies have suggested that CD4 antibody OKT4 and soluble CD4 can block IL-16 function. Recent data demonstrate that CD4 is not required for IL-16 function and suggest that another molecule acts as the major receptor. Because, cells from CD4 knockout mice are as responsi ve to IL-16 as their CD4 wild type equivalent in both assays testing for IL-16 function (chemotaxis and production of pro-inflammatory cytokines) (22) (23) .
IL-16 is released in vitro after histamine stimulation of CD8+ T cells and epithelial cells. IL-16 appears in the airways after histamine challenge and therefore could contribute to the earliest infiltration ofCD4+ T cells and eosinophils observed after antigen challenge due to histamine release from mast cells (24) (25) (26) (27) .
Neutralization of IL-16 with an anti-IL-16 treatment may reduce lymphocyte accumulation and may protect against acute allergy and lethal toxic shock syndrome.
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